Theoretical approaches to physical transformations of active pharmaceutical ingredients during manufacturing processes

被引:272
作者
Morris, KR [1 ]
Griesser, UJ
Eckhardt, CJ
Stowell, JG
机构
[1] Purdue Univ, Dept Ind & Phys Pharm, W Lafayette, IN 47907 USA
[2] Univ Innsbruck, Inst Pharmacognosy, A-6020 Innsbruck, Austria
[3] Univ Nebraska, Dept Chem, Lincoln, NE 68588 USA
基金
美国国家科学基金会;
关键词
process-induced transformation; wet granulation; drying; lyophilization; tabletting; Active Pharmaceutical Ingredient; crystallization; amorphous; polymorph; hydrate; solvate; phonon;
D O I
10.1016/S0169-409X(01)00100-4
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Processing-induced transformations (PITs) during pharmaceutical manufacturing are well known but difficult to predict and often difficult to control. This review of the concepts of transformations is couched in terms of the issues associated with identifying rate-controlling events from the materials side and the processing side. Specifically, the approach is reconciling the characteristic time scale of the structural change(s) in the material with the time scale of the processing-induced stress. This is definitely a model (or rather a melding of a group of existing theories) in development. This overview is a 'snapshot' of the authors' attempts to identify the categories of existing theories needed to encompass all of the relevant events for each possible PIT. The ultimate goal is to establish a Framework of concepts and theories for consideration. discussion, and modeling of PITs as well as to locate much of the relevant literature in the framework. (C) 2001 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:91 / 114
页数:24
相关论文
共 80 条
[1]   EVALUATION OF CRYSTALLINITY AND DRUG-RELEASE STABILITY OF DIRECTLY COMPRESSED THEOPHYLLINE HYDROPHILIC MATRIX TABLETS STORED UNDER VARIED MOISTURE CONDITIONS [J].
ADEYEYE, CM ;
ROWLEY, J ;
MADU, D ;
JAVADI, M ;
SABNIS, SS .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1995, 116 (01) :65-75
[2]   The molecular mobility of supercooled amorphous indomethacin as a function of temperature and relative humidity [J].
Andronis, V ;
Zografi, G .
PHARMACEUTICAL RESEARCH, 1998, 15 (06) :835-842
[3]   SOLID-STATE NMR AND IR FOR THE ANALYSIS OF PHARMACEUTICAL SOLIDS - POLYMORPHS OF FOSINOPRIL SODIUM [J].
BRITTAIN, HG ;
MORRIS, KR ;
BUGAY, DE ;
THAKUR, AB ;
SERAJUDDIN, ATM .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1993, 11 (11-12) :1063-1069
[4]  
Brittain HG, 1999, DRUGS PHARM SCI, V95, P331
[5]   PHYSICAL CHARACTERIZATION OF PHARMACEUTICAL SOLIDS [J].
BRITTAIN, HG ;
BOGDANOWICH, SJ ;
BUGAY, DE ;
DEVINCENTIS, J ;
LEWEN, G ;
NEWMAN, AW .
PHARMACEUTICAL RESEARCH, 1991, 8 (08) :963-973
[6]  
BRITTAIN HG, 1994, PHARM TECH, V8, P50
[7]  
BURGER A, 1979, MIKROCHIM ACTA, V2, P273
[8]   PHARMACEUTICAL SOLIDS - A STRATEGIC APPROACH TO REGULATORY CONSIDERATIONS [J].
BYRN, S ;
PFEIFFER, R ;
GANEY, M ;
HOIBERG, C ;
POOCHIKIAN, G .
PHARMACEUTICAL RESEARCH, 1995, 12 (07) :945-954
[9]  
Byrn S.R., 1999, Solid State Chemistry of Drugs, VSecond
[10]  
Callen H.B., 1985, THERMODYNAMICS INTRO, DOI 10.1119/1.19071